Bioequivalence Study of Eszopiclone Tablets, 3 mg Under Fasting Conditions
Status:
Completed
Trial end date:
2008-10-01
Target enrollment:
Participant gender:
Summary
This is an open-label, randomized, two-period, two-treatment, two-sequence, balanced, single
dose, crossover, oral bioequivalence study in healthy, adult, human subjects under fasting
conditions.